📰 Research Update News
Page 4 - Research Update News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Research Update. Real-time updates on events, politics, business and more.
September 18, 2023
EQS-News: / Key word(s): Research Update/Research Update ReNeuron Group (RENE): A step forward on the Exosome delivery platform 18.09.2023 / 08:15 CET/CEST The issuer is solely responsible for the content of this announcement. London, UK, 18 September 2023 ReNeuron Group (RENE): A step forwa...
September 3, 2023
Research Update: Israel-Based The Phoenix Insurance Co. Assigned A- Ratings; Outlook Stable ...
August 3, 2023
Looking for honest Alpha BRAIN reviews 2023? Read on to learn everything you need to know about Alpha BRAIN and its alternatives.
June 2, 2023
EQS-News: Deutsche Rohstoff AG / Key word(s): Research Update Deutsche Rohstoff AG: AlsterResearch initiates Coverage 01.06.20...
June 1, 2023
EQS-News: Deutsche Rohstoff AG / Key word: Research Update Deutsche Rohstoff AG: AlsterResearch initiates Coverage 01.06.2023 / 15:39 CET/CEST The issuer is solely responsible... | June 1, 2023
April 28, 2023
Research Update: Italian Multi-Utility Iren SpA Upgraded To BBB On Successful Plan Execution; Outlook Stable ... | April 28, 2023
April 20, 2023
(Archived document, may contain errors)
April 11, 2023
EQS-News: Defence Therapeutics Inc. / Key word(s): Research UpdateDEFENCE BREAKTHROUGH: SUCCESSFULLY ENGINEERED ACCUM(TM) -mRNA VACCINE CREATING A NEW VACCINE PLATFORM. THE IN VIVO ACCUM(TM)-mRNA CANCER VACCINE PROGRAM BEGINS 11.04.2023 / 08:00 CET/CESTThe issuer is solely responsible for the content of this announc...
April 11, 2023
EQS-News: Defence Therapeutics Inc. / Key word(s): Research Update DEFENCE BREAKTHROUGH: SUCCESSFULLY ENGINEERED ACCUM(TM) -mRNA VACCINE CREATING A NEW VACCINE PLATFORM. THE IN VIVO ACCUM(TM)-mRNA CANCER VACCINE PROGRAM BEGINS 11.04.2023 / 08:00 CET/CEST The issuer is solely responsible for the ...
April 3, 2023
Research Update: JSL S.A. Global Scale Rating Raised To BB- On Larger Scale And Steady Leverage; Outlook Stable ... | April 3, 2023